Identification and significance of cell markers in leukemia and lymphoma

Annual Review of Medicine
R A Warnke, M P Link

Abstract

The identification of markers of human hematopoietic cell differentiation and function has revealed the nature of the proliferating cell in many lymphoid neoplasms and demonstrated marked phenotypic heterogeneity in traditional subgroups. Selected markers are described that define common subgroups of lymphoid leukemia and non-Hodgkin's lymphoma. The identification of cell markers has significant implications for accuracy of diagnosis, for predicting clinical characteristics, and for understanding the biology of these diseases.

Citations

Mar 12, 2009·Science in China. Series C, Life Sciences·Fan YangMian Long
May 19, 2017·Lymphatic Research and Biology·Shaghayegh HarbiPaolo Mignatti
Jan 1, 1986·Scandinavian Journal of Haematology·H C Kluin-NelemansW Sizoo
Oct 1, 1989·European Journal of Haematology·J DemeterD Lehoczky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.